Ofer Agid, Department of Psychiatry, University of Toronto, Toronto, Canada
Thomas R. E. Barnes, Emeritus Professor of Clinical Psychiatry, Imperial College London, London, UK
Majella Byrne, Department of Psychology, King's College London, London, UK
Araba Chintoh, Department of Psychiatry, University of Toronto, Toronto, Canada
Christoph U. Correll, Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York, USA
John M. Davis, Psychiatric Institute, University of Illinois Medical School, and Maryland Psychiatric Research Center, Chicago and Baltimore, USA
Siobhan Gee, Principal Pharmacist, National Psychosis Unit and Liaison Psychiatry, South London and Maudsley NHS Foundation Trust, London, UK
Oliver Howes, Professor of Molecular Psychiatry, King's College London, London, Institute of Medical Sciences (Imperial College London) and Maudsley Hospital, London, UK
Suzanne Jolley, Department of Psychology, King's College London, London, UK
Elizabeth Kuipers, Institute of Psychiatry, Psychology & Neuroscience at King's College London, Department of Psychology, London, UK
Stephen J. Kaar, King's College London and Maudsley Hospital, London, UK
John Kane, Senior Vice President, Behavioral Health Services, Northwell Health, New York, USA
John Lally, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
Stefan Leucht, Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany
Jimmy Lee, Institute of Mental Health, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
Robert McCutcheon, Wellcome Trust Clinical Research Training Fellow, King's College London, London, UK
James H. MacCabe, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
Stephen Marder, UCLA Psychiatry & Biobehavioral Science, VA Greater LA Healthcare Sys, Los Angeles, USA
Seiya Miyamoto, Department of Psychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan
Nobumi Miyake, Department of Neuropsychiatry, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Japan
Jimmi Nielsen, Mental Health Centre Glostrup, Mental Health Services,Capital Region of Denmark, University of Copenhagen, Glostrup, Denmark
Juliana Onwumere, Institute of Psychiatry, Psychology & Neuroscience at King's College London, Department of Psychology, London, UK
Emmanuelle Peters, Reader in Clinical Psychology & PICuP Clinic Director, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK
Steven Potkin, Director Pharmacogenomics and Clinical Neuroscience, Long Beach Veterans Administration Health Care System, California, USA
Gary Remington, Department of Psychiatry, University of Toronto, Toronto, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada
Christopher Rohde, Mental Health Centre Glostrup, Mental Health Services, Capital Region of Denmark, University of Copenhagen, Glostrup, Denmark
Robert C. Smith, Department of Psychiatry New York University School of Medicine and Nathan Kline Institute for Psychiatric Research, New York, USA
Hiroyoshi Takeuchi, Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
David Taylor, Institute of Pharmaceutical Science, King's College London, London, UK
Yvonne Yang, UCLA Psychiatry & Biobehavioral Science/ VA Greater LA Healthcare Sys, Los Angeles, USA
